Metabolite-Imaging Mass Spectrometry to Guide Brain Surgery

Back to all technologies
Download as PDF
2013-COOK-66578
Currently, one of the main treatments for brain tumors is surgery. Performing a tumor resection within the brain is difficult because it is not easy to distinguish tumor boundaries from healthy brain tissue. Existing imaging techniques do not provide the necessary molecular information to distinguish tumor boundaries. An unclear boundary between a tumor and healthy tissue can lead to inadequate resection if enough of the tumor remains and neurological damage if healthy tissue is removed.

Purdue University researchers have developed a method for surgeons to define tumor margins quickly during surgery using miniature mass spectrometers or separate ionization techniques. This method overcomes the need for prepping, staining, and evaluation by a pathologist. It is also possible to adapt this method for other types of cancer surgery.

Advantages:
-Overcomes need for prepping, staining, and evaluation by a pathologist
-Can be used to determine tumor boundaries

Potential Applications:
-Medical/Healthcare
-Cancer surgery
Oct 12, 2015
CON-Patent
United States
9,921,233
Mar 20, 2018

Jun 4, 2013
CIP-Patent
United States
9,546,979
Jan 17, 2017

May 18, 2012
Utility Patent
United States
9,157,921
Oct 13, 2015

Jan 17, 2017
CON-Patent
United States
(None)
(None)

Mar 13, 2014
Utility Patent
United States
(None)
(None)

Mar 15, 2013
Provisional-Patent
United States
(None)
(None)

Mar 12, 2013
Provisional-Patent
United States
(None)
(None)

May 18, 2011
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
1801 Newman Road
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org